单位(元)易方达医疗保健行业混合A(110023)利润表 |
| 报告期 |
2025/12/31 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
| 收入 |
1,311,106,332 |
1,023,921,142 |
-556,809,269 |
-743,934,501 |
| 利息收入 |
1,168,759 |
637,294 |
1,520,950 |
752,043 |
| 其中:存款利息收入 |
1,168,759 |
637,294 |
1,520,950 |
752,043 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益 |
947,820,494 |
265,056,340 |
-146,921,445 |
-150,698,682 |
| 其中:股票投资收益 |
924,301,676 |
246,504,362 |
-202,913,743 |
-184,185,997 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
1,484,325 |
2,611 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
23,518,818 |
18,551,977 |
54,507,972 |
33,484,703 |
| 公允价值变动收益 |
358,231,656 |
756,500,504 |
-414,078,718 |
-594,997,331 |
| 汇兑收益 |
- |
- |
- |
- |
| 其他收入 |
3,885,424 |
1,727,004 |
2,669,944 |
1,009,468 |
| 费用 |
65,223,632 |
34,585,080 |
82,060,201 |
42,041,508 |
| 管理人报酬 |
54,101,204 |
28,715,281 |
68,898,974 |
35,353,445 |
| 托管费 |
9,016,867 |
4,785,880 |
11,483,162 |
5,892,241 |
| 销售服务费 |
1,841,050 |
951,358 |
1,414,747 |
640,505 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
264,510 |
132,562 |
263,305 |
155,308 |
| 利润总额 |
1,245,882,701 |
989,336,061 |
-638,869,470 |
-785,976,010 |
| 减:所得税费用 |
- |
- |
- |
- |
| 净利润 |
1,245,882,701 |
989,336,061 |
-638,869,470 |
-785,976,010 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。